
Reset all filters
01 5Xopenex
Main Therapeutic Indication : Respiratory Disorders
Currency : USD
2020 Revenue in Millions : 47
2019 Revenue in Millions : 40
Growth (%) : 20
Main Therapeutic Indication : Respiratory Disorders
Currency : USD
2016 Revenue in Millions : 50
2015 Revenue in Millions : 61
Growth (%) : -18
Main Therapeutic Indication : Respiratory Disorders
Currency : USD
2017 Revenue in Millions : 67
2016 Revenue in Millions : 102
Growth (%) : -34
Main Therapeutic Indication : Respiratory Disorders
Currency : USD
2018 Revenue in Millions : 41
2017 Revenue in Millions : 36
Growth (%) : 15%
Main Therapeutic Indication : Respiratory Disorders
Currency : USD
2019 Revenue in Millions : 38
2018 Revenue in Millions : 43
Growth (%) : -11